本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2026/10/271 分钟阅读
Capitainer Initiates Clinical Sampling for HbA1c FDA 510(k) Study
本地自动翻译 · 来源原始语言
摘要
STOCKHOLM, Oct. 27, 2026 — Capitainer, a Swedish provider of volumetric microsampling solutions, has reached an important milestone in its U.S. regulatory strategy with the first clinical sample collecte…
来源原始语言: PR Newswire UK — News Releases打开原始公告 →